![Hero Image](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fbanner-two-shape-left.6c4ab631.png&w=3840&q=75)
![Hero Image](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fhero-right-top.b8bd1734.webp&w=3840&q=75)
Last updated at 23 hours ago
Director
DIN: 10388975
Karishma Sharma is currently associated with 2 companies in various capacities such as Additional Director and Designated Partner. They serve as a Director at MEGMENTO PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10388975.Karishma Sharma is currently involved in 2 different roles. Their most recent position is with FOODIVERSAL STUDIOS LLP as a Designated Partner. The first company Karishma Sharma was appointed to was MEGMENTO PHARMACEUTICALS PRIVATE LIMITED. Karishma Sharma is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Karishma Sharma is currently associated with 2 companies in various capacities such as Additional Director and Designated Partner. They serve as a Director at MEGMENTO PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10388975.Karishma Sharma is currently involved in 2 different roles. Their most recent position is with FOODIVERSAL STUDIOS LLP as a Designated Partner. The first company Karishma Sharma was appointed to was MEGMENTO PHARMACEUTICALS PRIVATE LIMITED. Karishma Sharma is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (0)
3 Months 2 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
MEGMENTO PHARMACEUTICALS PRIVATE LIMITED | Additional Director | 09-Nov-2023 |